Get in touch
Welcome to Genomate Health, the company behind the world's first AI-powered clinical decision support system for precision oncology. We combine oncology expertise with computational reasoning to analyze each patient's complete molecular profile and provide evidence-based treatment rankings that help physicians make more informed, personalized treatment decisions.
Over more than three decades of research, we developed the computational reasoning platform that became Genomate®, bringing together oncology, genomics, and artificial intelligence to support more personalized cancer treatment.
We challenge the status quo and push precision oncology forward.
We challenge the status quo and push
recision oncology forward.
By combining medical expertise with computational reasoning, we create solutions that open new possibilities for patients and physicians alike.
Everything we build is backed by rigorous scientific evidence.
Our commitment to quality, transparency, and ethics ensures patients, physicians, and partners can trust every decision we support.
Behind every decision we make, there is a patient. Our purpose is to give time, hope, and better outcomes to people facing some of life’s toughest challenges.
By building with empathy, we ensure our solutions serve the real needs of patients, doctors, and caregivers.
We challenge the status quo and push precision oncology forward.
We challenge the status quo and push precision oncology forward. By combining medical expertise with computational reasoning, we create solutions that open new possibilities for patients and physicians alike.
Everything we build is backed by rigorous scientific evidence. Our commitment to quality, transparency, and ethics ensures patients, physicians, and partners can trust every decision we support.
Behind every decision we make, there is a patient. Our purpose is to give time, hope, and better outcomes to people facing some of life’s toughest challenges. By building with empathy, we ensure our solutions serve the real needs of patients, doctors, and caregivers.
Progress in precision oncology depends on collaboration. We work with leading hospitals, research institutions, diagnostic laboratories, technology companies, and healthcare organizations to bring personalized cancer care to more patients worldwide.
.avif)
